Humacyte Inc.

NASDAQ: HUMAW · Real-Time Price · USD
0.49
-0.03 (-5.50%)
At close: Aug 01, 2025, 3:43 PM

Humacyte Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
44.94M 80.45M 149.77M 217.5M
Short-Term Investments
n/a n/a 2.11M 8M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
51.46M 32K -50.09M -57.19M
Receivables
n/a n/a 31K 176K
Inventory
n/a n/a -31K n/a
Other Current Assets
2.92M 144K 2.3M n/a
Total Current Assets
47.86M 83.28M 154.21M 229.34M
Property-Plant & Equipment
38.55M 44.95M 50.09M 57.19M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
90.01M 44.95M 50.09M 57.19M
Total Assets
137.87M 128.22M 204.3M 286.53M
Account Payables
4.49M 6.49M 1.59M 2.09M
Deferred Revenue
n/a n/a n/a 4.73M
Short-Term Debt
2.92M n/a 8.57M n/a
Other Current Liabilities
6.21M 4.1M n/a n/a
Total Current Liabilities
19.95M 18.44M 19.58M 11.05M
Long-Term Debt
63.35M 38.6M 20.34M 27.36M
Other Long-Term Liabilities
93.11M 40.74M 28.61M 104.16M
Total Long-Term Liabilities
170.59M 96.23M 67.79M 153.31M
Total Liabilities
190.54M 114.68M 87.37M 164.36M
Total Debt
16.54M 57.51M 47.76M 48.47M
Common Stock
13K 10K 543.47M 536.75M
Retained Earnings
-686.01M -537.31M -426.54M -414.57M
Comprehensive Income
n/a n/a n/a -822.77M
Shareholders Equity
-52.67M 13.55M 116.93M 122.17M
Total Investments
n/a 209K 2.11M 8M